By contrast, GalNT1 can exhibit a mucin-independent function in cancer and be implicated in other pathways, such as EGFR signaling, by increasing EGFR degradation via decreasing of EGFR O-glycosylation [52]. The gene discussed is GALNT1; the disease is cancer.